Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myofibroblastic differentiation in simple peritoneal sclerosis.

G Del Peso1, J A Jimenez-Heffernan, M A Bajo

  • 1Department of Nephrology, University Hospital La Paz, Paseo de la Castellana 261, Madrid 28046, Spain. gpeso@yahoo.com

The International Journal of Artificial Organs
|March 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hippocampo-supramammillary coupling across sleep and wake.

Scientific reports·2026
Same author

Hippocampal synchrony dynamically gates cortical connectivity across brain states.

Scientific reports·2026
Same author

Increased expression of Toll-like receptors and associated alarmins in temporal arteries of patients with giant cell arteritis.

Molecular medicine (Cambridge, Mass.)·2025
Same author

Prevalence of urinary tract cancer in the Spanish cohort of the IDENTIFY study.

Actas urologicas espanolas·2023
Same author

Impact of BK Polyomavirus Plasma Viral Load in Kidney Transplant Outcomes.

Transplantation proceedings·2022
Same author

Acute Kidney Injury and Urinary and Histopathological Disorders in Kidney Transplant Patients with SARS-CoV-2 Infection.

Transplantation proceedings·2022

Myofibroblasts, key indicators of fibrosis, are present in early peritoneal dialysis (PD) patients, even with minor changes. Their absence in non-PD uremic patients suggests uremia-related fibrosis differs significantly.

Area of Science:

  • Nephrology
  • Histopathology
  • Peritoneal Dialysis Research

Background:

  • Fibrosis is a common complication in patients undergoing peritoneal dialysis (PD).
  • Myofibroblasts are associated with active fibrosis, but their role in PD-related peritoneal changes is not fully understood.
  • Understanding myofibroblast presence can help in early detection and management of peritoneal complications.

Purpose of the Study:

  • To investigate the presence of myofibroblasts in peritoneal biopsies from PD patients with simple sclerosis and compare them to non-PD uremic patients.
  • To determine correlations between myofibroblast presence and various functional and morphological peritoneal parameters in PD patients.
  • To assess if myofibroblasts are indicative of early-stage fibrosis in PD.

Main Methods:

Related Experiment Videos

  • Peritoneal biopsies were obtained from three groups: normal controls (n=15), non-PD uremic patients (n=16), and PD patients (n=32).
  • Immunohistochemistry was used to detect myofibroblasts (alfa-smooth muscle actin), VEGF, bcl-2, and progesterone receptor.
  • Morphological and functional peritoneal parameters were analyzed alongside myofibroblast expression.

Main Results:

  • Myofibroblasts were detected in 56.3% of PD patients with simple sclerosis, primarily in the submesothelial area.
  • No myofibroblasts were found in normal controls or non-PD uremic patients.
  • In PD patients, myofibroblast presence did not correlate with dialysis duration, solute transport, peritonitis, or morphological changes; VEGF was noted in some fibroblastic cells.

Conclusions:

  • Myofibroblasts serve as reliable indicators of early-stage fibrosis in PD patients, even with minimal morphological alterations.
  • Their presence is not limited to severe conditions like sclerosing peritonitis or long-term PD treatment.
  • The absence of myofibroblasts in non-PD uremic patients suggests that uremia-induced fibrosis may not involve significant myofibroblast activity.